| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 73.8 | ¤41,820 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 70.3 | ¤13,889 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 61.2 | ¤9,162 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 85.9 | ¤6,100 | CN |
| 688336.CN | Sunshine Guojian Pharmaceutical (Shangha | 64.3 | ¤5,589 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300515.CN | Hunan Sundy Science and Technology Co., | 79.9 | ¤616 | CN |
| 603309.CN | WELL LEAD MEDICAL CO LTD Class A | 65.0 | ¤631 | CN |
| 688410.CN | SWS Hemodialysis Care Co., Ltd. Class A | 63.7 | ¤792 | CN |
| 300871.CN | Hvsen Biotechnology Co. Ltd. Class A | 65.8 | ¤798 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 75.7 | ¤1,101 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 70.3 | 20 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 67.3 | 19 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 75.7 | 11 | CN |
| 300357.CN | Zhejiang Wolwo Bio-Pharmaceutical Co., L | 62.4 | 11 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 61.2 | 10 | CN |
| 600750.CN | China Resources Jiangzhong Pharmaceutica | 58.3 | 10 | CN |
| 600211.CN | Tibet Rhodiola Pharmaceutical Holding Co | 67.3 | 9 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 75.2 | 9 | CN |
| 688278.CN | Xiamen Amoytop Biotech Co., Ltd. Class A | 83.1 | 7 | CN |
| 002773.CN | Chengdu Kanghong Pharmaceutical Group Co | 62.2 | 6 | CN |
| Average Market Cap | ¤4,404 |
| Median Market Cap | ¤2,066 |
| Avg. 3 Mo. Dollar Vol. | ¤42,472,022 |
| Avg. 3 Mo. Trading Vol. | 6,592,082 |
| Last Rebalance Date | 12/22/2025 |
| Companies Replaced | 15 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 21.4 |
| Forward P/E Ratio (12 Mo.) | 15.1 |
| Price/Book Ratio | 3.8 |
| Avg. Revenue Chg. - 3 Yr | 45.4% |
| Avg. Op. Income Chg. - 3 Yr. | 126.3% |
| Avg. EPS Growth - 3 Yr. | 28.8% |
| Avg. EPS Growth - 1 Yr. | 16.4% |
| Avg. Operating Margin | 26.7% |
| Avg. LT Debt to Total Capital | 6.6% |
| Avg. Return on Equity | 16.7% |
| Dividend Yield | 1.4% |
| China Health Care Index | 67.29 |
| China | 100.0% |
